Table 5.

Costs: PS-matched alloHSCT-NIPC patients and alloHSCT non-NIPC patients

AlloHSCT-NIPC patients (years 1,2)† ($)AlloHSCT non-NIPC patients (years 1,2)† ($)
Year −1Year 1Year 2Year −1Year 1Year 2
n = 155n = 155n = 73n = 155n = 155n = 74
Inpatient costs 161 326 ± 220 463 452 475 ± 987 060 100 862 ± 268 531 200 286 ± 254 098 300 202 ± 369 453 50 017 ± 153 685 
ER costs 647 ± 1763 676 ± 1195 530 ± 1177 648 ± 1510 657 ± 2229 439 ± 1117 
Outpatient costs 67 873 ± 61 258 95 476 ± 105 479 55 207 69 012* 65 249 ± 44 532 89 768 ± 79 073 32 208 ± 40 351* 
 Physician office costs 6095 ± 8813 6346 ± 11 531 5163 ± 8175 7189 ± 8419 8153 ± 12 483 4158 ± 9408 
 Outpatient hospital costs 58 124 ± 58 581 79 611 ± 103 434 46 255 ± 66 538* 53 310 ± 44 005 72 464 ± 76 650 24 378 ± 29 101* 
 Other outpatient costs 3654 ± 6394 9519 ± 17 234 3789 ± 8383 4751 ± 9417 9151 ± 22 501 3672 ± 18 194 
 Pulmonary function test costs‡ 491 ± 742 519 ± 834* 661 ± 952 722 ± 1381 587 ± 1984* 463 ± 1529 
Medication costs 27 622 ± 49 880 19 243 ± 31 079 15 671 ± 38 759 33 654 ± 61 905 21 772 ± 43 206 10 268 ± 23 417 
 Chemotherapy 25 558 ± 48 627 9660 ± 26 216 10 862 ± 36 389 30 943 ± 61 299 9029 ± 21 320 6738 ± 20 571 
 Immunosuppressive agents 505 ± 3980 3990 ± 5811 2554 ± 4080 868 ± 5086 5117 ± 18 152 2016 ± 4443 
 Antifungals 970 ± 8561 1605 ± 5260 396 ± 1524 830 ± 5210 2757 ± 17 967 226 ± 1660 
 Antibiotics 305 ± 1140 447 ± 891 277 ± 466 377 ± 2797 503 ± 1239 234 ± 793 
 Antivirals 254 ± 1007 3493 ± 6211 517 ± 6427 630 ± 3861 4336 ± 9926 1038 ± 3874 
Total 257 468 ± 255 419 567 870 ± 1 014 222 172 269 ± 323 740 299 837 ± 263 313 412 400 ± 404 915 92 932 ± 170 863 
AlloHSCT-NIPC patients (years 1,2)† ($)AlloHSCT non-NIPC patients (years 1,2)† ($)
Year −1Year 1Year 2Year −1Year 1Year 2
n = 155n = 155n = 73n = 155n = 155n = 74
Inpatient costs 161 326 ± 220 463 452 475 ± 987 060 100 862 ± 268 531 200 286 ± 254 098 300 202 ± 369 453 50 017 ± 153 685 
ER costs 647 ± 1763 676 ± 1195 530 ± 1177 648 ± 1510 657 ± 2229 439 ± 1117 
Outpatient costs 67 873 ± 61 258 95 476 ± 105 479 55 207 69 012* 65 249 ± 44 532 89 768 ± 79 073 32 208 ± 40 351* 
 Physician office costs 6095 ± 8813 6346 ± 11 531 5163 ± 8175 7189 ± 8419 8153 ± 12 483 4158 ± 9408 
 Outpatient hospital costs 58 124 ± 58 581 79 611 ± 103 434 46 255 ± 66 538* 53 310 ± 44 005 72 464 ± 76 650 24 378 ± 29 101* 
 Other outpatient costs 3654 ± 6394 9519 ± 17 234 3789 ± 8383 4751 ± 9417 9151 ± 22 501 3672 ± 18 194 
 Pulmonary function test costs‡ 491 ± 742 519 ± 834* 661 ± 952 722 ± 1381 587 ± 1984* 463 ± 1529 
Medication costs 27 622 ± 49 880 19 243 ± 31 079 15 671 ± 38 759 33 654 ± 61 905 21 772 ± 43 206 10 268 ± 23 417 
 Chemotherapy 25 558 ± 48 627 9660 ± 26 216 10 862 ± 36 389 30 943 ± 61 299 9029 ± 21 320 6738 ± 20 571 
 Immunosuppressive agents 505 ± 3980 3990 ± 5811 2554 ± 4080 868 ± 5086 5117 ± 18 152 2016 ± 4443 
 Antifungals 970 ± 8561 1605 ± 5260 396 ± 1524 830 ± 5210 2757 ± 17 967 226 ± 1660 
 Antibiotics 305 ± 1140 447 ± 891 277 ± 466 377 ± 2797 503 ± 1239 234 ± 793 
 Antivirals 254 ± 1007 3493 ± 6211 517 ± 6427 630 ± 3861 4336 ± 9926 1038 ± 3874 
Total 257 468 ± 255 419 567 870 ± 1 014 222 172 269 ± 323 740 299 837 ± 263 313 412 400 ± 404 915 92 932 ± 170 863 

This table shows the HRU for matched alloHSCT patients (NIPC vs non-NIPC) in the follow-up years 1 and 2 compared with the period before transplant.

†

Years 3 through 5 in supplemental Materials.

‡

Pulmonary function test includes spirometry, lung function volume, lung diffusion capacity, and plethysmography.

*

P value ≤ .05.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal